Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul class="summary-list"><li>Russian President <keyword id="43440" type="PERSON" weightage="60" keywordseo="Vladimir-Putin">Vladimir Putin</keyword> received a <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> behind closed doors Tuesday, officials said.</li><li>It was one of the three Russian-made vaccines, per the Kremlin, which did not get more specific.</li><li>Putin, who usually loves photo ops, is out of step with world leaders who got vaccinated in public.</li></ul>Russian President Vladimir Putin is said to have received a COVID-19 vaccine Tuesday but has not disclosed which one."Putin was vaccinated against the coronavirus," Dmitry Peskov, Putin's top spokesman, <a href="https://edition.cnn.com/2021/03/23/europe/russia-putin-vaccination-intl/index.html?utm_term=link&amp;utm_content=2021-03-23T20%3A00%3A14&amp;utm_source=twCNN&amp;utm_medium=socialedium=social">told CNN</a>. "[He] feels good. Tomorrow he has a full working day."Peskov earlier said the vaccination would not be a public event because Putin "doesn't like" the idea of being on camera for it, according to CNN.He refused to say which vaccine Putin got but said it was one of the three <a href="https://www.reuters.com/article/us-health-coronavirus-putin-vaccine-idUSKBN2BF149?taid=6059ee909d53350001d9cf6f&amp;utm_campaign=trueAnthem:+Trending+Content&amp;utm_medium=trueAnthem&amp;utm_source=twitterurce=twitter">available in Russia</a>: Sputnik V, EpiVacCorona, and CoviVac."We are deliberately not saying which shot the president will get, noting that all three Russian [-made] vaccines are absolutely reliable and effective," Peskov said, <a href="https://www.reuters.com/article/us-health-coronavirus-putin-vaccine-idUSKBN2BF149?taid=6059ee909d53350001d9cf6f&amp;utm_campaign=trueAnthem:+Trending+Content&amp;utm_medium=trueAnthem&amp;utm_source=twitterurce=twitter">according to Reuters</a>.Asked how anyone would know that Putin had really been vaccinated, Peskov responded, "You will have to take our word for it."Many noted that deciding to leave the cameras behind was out of character for Putin, who is known for posed photo ops:It is also a change <a href="https://nymag.com/intelligencer/article/congress-joe-biden-get-covid-19-vaccine.html">from other world leaders</a> who chose to get their shots publicly to encourage trust in vaccination.President Joe Biden was injected publicly during his transition to the presidency. UK Prime Minister Boris Johnson took his jab in public last week.<div type="image" title="Joe Biden vaccine" height="1333" width="1777" msid="81670489" hostid="261"></div>Putin's preference for private vaccination is shared by former President Donald Trump, who was vaccinated in January while still in office but did not make that fact public. News outlets <a href="https://www.businessinsider.com/trump-got-the-covid-19-vaccine-at-the-white-house-in-january-2021-3">first reported it March 1</a>.Sputnik V has been approved in <keyword id="6358826" type="LOCATION" weightage="60" keywordseo="Russia">Russia</keyword> for more than 10 months, and Putin, 68, has been eligible for it since December, <a href="https://www.nytimes.com/live/2021/03/23/world/covid-vaccine-coronavirus-cases#covid-vaccine-putin">The New York Times</a> reported.Some <a href="https://www.bbc.co.uk/news/world-europe-56498847">had questioned</a> why Putin had not received a vaccine until Tuesday, long after he told the media that <a href="https://www.businessinsider.com/russia-coronavirus-vaccine-putin-wont-take-until-approved-2020-11">one of his daughters</a> had received one.Sputnik V was found to be <a href="https://www.businessinsider.com/russia-coronavirus-vaccine-phase-3-interim-results-lancet-2021-2">91.6% effective</a> against symptomatic COVID-19 in an analysis published in February. EpiVacCorona and CoviVac were <a href="https://www.dw.com/en/two-more-russian-vaccines-what-we-do-and-dont-know/a-56811025https://www.reuters.com/article/health-coronavirus-russia-vaccine/update-2-russia-approves-its-third-covid-19-vaccine-covivac-idUSL1N2KQ055">approved</a> in Russia in October and last month, respectively, but neither has completed late-stage trials, which confirm vaccine safety and efficacy.5.9 million Russians have received a COVID-19 vaccine at home, <a href="https://ourworldindata.org/covid-vaccinations?country=TUR~RUS">according to Our World in Data</a>, out of a population of over 145 million.Peskov, the Kremlin representative, said the demand abroad for Sputnik V exceeded supply so promotion was not needed, <a href="https://www.nytimes.com/live/2021/03/23/world/covid-vaccine-coronavirus-cases#covid-vaccine-putin">The Times reported</a>.The shot is now approved in 56 countries, according to the <a href="https://twitter.com/sputnikvaccine/status/1374274467816423425?s=20">Sputnik V representatives</a>. But it is <a href="https://www.businessinsider.com/russia-demands-ema-apology-official-called-sputnik-vaccine-russian-roulette-2021-3">not authorized in the European Union</a>, <a href="https://www.businessinsider.com/us-uk-approval-not-priority-russia-covid-19-vaccine-sputnik-v-2021-2">the UK, or the US</a>.Russia plans to vaccinate one in 10 people in the world with Sputnik V this year, <a href="https://www.businessinsider.com/russia-sputnik-vaccine-covid-doses-tenth-world-2021-3">Insider's Kate Duffy reported on March 12</a>.

Putin said he got a coronavirus vaccine but released no photos and won't say which one he took

<ul><li>Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response</li><li>Vladimir Putin calls for a joint effort by the BRICS countries on the development of the coronavirus vaccines, suggesting that Sputnik V vaccine could be produced in China and India.</li><li>Moderna’s COVID-19 vaccine shows over 94% efficacy, Indian government is in talks with the US biotech giant.</li><li>Vaccine maker Bharat Biotech has started Phase III trials of Covaxin, India's first indigenous vaccine for COVID-19.</li></ul>After registering over 48 million COVID-19 infections, the World Health Organisation is <a href="https://www.livemint.com/science/health/who-expects-to-see-covid-19-vaccine-by-end-of-2020-at-earliest-11602548070399.html">finally expecting</a> a COVID-19 vaccine by the end of 2020 or early 2021. It takes a decade or two to design, test, and launch an effective vaccine that can protect billions of people from diseases. However, COVID-19 has forced researchers to fast-track the vaccine making process. Here’s a look at COVID-19 vaccine updates from around the world — Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response Preliminary trial results show that Sinovac Biotech’s COVID-19 vaccine CoronaVac triggers a quick immune response. However the level of antibodies produced was lower than in people who recovered from the disease, <a href="https://in.reuters.com/article/us-health-coronavirus-sinovac/sinovacs-covid-19-vaccine-induces-quick-immune-response-study-idUSKBN27X354">Reuters </a>reported. The research that was published in a Lancet study shows that the vaccine is safe and could provide sufficient protection. Russian President: Sputnik V vaccine could be produced in India and China Russian President Vladimir Putin called for a joint effort by the BRICS countries on the development of the coronavirus vaccines as he suggested that Russia's Sputnik V vaccine against COVID-19 could be produced in China and India, which are members of the five-nation bloc. "We believe it is important to speed up the establishment of the centre for development and research of BRICS vaccines, which we agreed to do two years ago, upon the initiative of our South African friends," Putin said while addressing the 12th BRICS summit via videoconferencing. Moderna’s COVID-19 vaccine shows over 94% efficacy, Indian government is in talks with the US biotech giant. India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine candidate, which the firm said has shown 94.5 percent efficacy, official sources said on Monday. "We are in dialogue not only with Moderna, but also with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila over the progress of the clinical trials of each of the vaccine candidates and where their vaccines stand in terms safety, immunogenicity and efficacy, and regulatory approvals," a source said. On Monday, <a href="https://www.businessinsider.in/science/health/news/moderna-says-its-coronavirus-vaccine-is-94-5-effective-against-covid-19-a-crucial-victory-in-the-fight-against-the-pandemic/articleshow/79247349.cms">Moderna </a>said that its vaccine candidate against COVID-19 was found to have an efficacy of 94.5 percent. Bharat Biotech begins phase III trials for Covaxin Vaccine maker <a href="https://www.businessinsider.in/india/news/indias-first-vaccine-candidate-covaxins-phase-3-trials-begin/articleshow/79249854.cms">Bharat Biotech</a> has started Phase III trials of Covaxin, India's first indigenous vaccine for COVID-19. The Phase III trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). According to a <a href="https://in.reuters.com/article/health-coronavirus-india-vaccine/exclusive-india-made-covid-19-vaccine-could-be-launched-as-early-as-february-government-scientist-idINKBN27L0WU">Reuters report</a>, Bharat Biotech COVAXIN could be launched as early as February as studies have so far shown it is safe and effective. Bharat Biotech had earlier hoped to launch it only in the second quarter of next year. EU signs a deal with German biotech firm CureVac According to a <a href="https://in.reuters.com/article/health-coronavirus-eu-curevac/eu-to-okay-deal-with-curevac-for-supply-of-up-to-405-million-covid-vaccines-idINKBN27W1Z5">Reuters </a>report, the European Union has signed a deal with German biotech firm CureVac to buy upto 405 million doses of its potential COVID-19 vaccine. European Commission President Ursula von der Leyen said this deal takes the total supplies secured by the bloc to nearly 2 billion doses. The deal with CureVac follows EU supply agreements with AstraZeneca, Johnson &amp; Johnson, Sanofi, and Pfizer for a combined 1.4 billion doses of their potential vaccines Pfizer’s COVID vaccine is 90% effective The latest data from t<a href="https://www.businessinsider.in/science/health/news/pfizers-covid-19-vaccine-is-90-effective-in-preventing-coronavirus-in-those-who-havent-been-infected-ever-before/articleshow/79130097.cms">he US pharmaceutical giant Pfizer</a> and German biotech firm BioNTech late-stage vaccine trial shows that their COVID-19 vaccine is <a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against">90% more effective</a> in preventing infection if a person has never come in contact with it before. This means that those who get the vaccine will be protected within 28 days of the first dose — and there is only a two-dose schedule. Eli Lilly gets USFDA nod for COVID antibody drug in emergency use The US Food and Drug Administration (USFDA) on Monday has granted emergency approval to a synthetic <a href="https://www.bloombergquint.com/onweb/eli-lilly-covid-19-antibody-therapy-gets-emergency-fda-clearance">antibody treatment against COVID-19 developed by Eli Lilly</a>. The drug was shown to reduce the risk of hospitalization and emergency room visits. The drug, Bamlanivimab, is the first major drug to be approved that was designed specifically against the coronavirus. SEE ALSO:<a href="https://www.businessinsider.in/science/health/news/moderna-says-its-coronavirus-vaccine-is-94-5-effective-against-covid-19-a-crucial-victory-in-the-fight-against-the-pandemic/articleshow/79247349.cms" data-type="tilCustomLink"> Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic</a> <a href="https://www.businessinsider.in/stock-market/news/dow-soars-375-points-to-near-record-as-modernas-vaccine-update-boosts-investor-optimism/articleshow/79249468.cms" data-type="tilCustomLink">Dow soars 450 points to new record as Moderna's vaccine update boosts investor optimism</a>

COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response

Moscow, Russian President Vladimir <keyword id="6355086" type="PERSON" weightage="20" keywordseo="Putin">Putin</keyword> on Wednesday instructed the government to begin large-scale vaccinations against the <keyword id="10370676" type="UNKNOWN" weightage="20" keywordseo="coronavirus-next-week">coronavirus next week</keyword>. <keyword id="1480647" type="ORGANIZATION" weightage="20" keywordseo="Medical-workers">Medical workers</keyword> and teachers, who are two high-risk groups, will be among the first to get shots, Putin said at an online meeting with Deputy Prime Minister Tatyana Golikova and other senior officials, Xinhua news agency reported. According to the president, the number of produced vaccine doses will reach two million in the coming days. "I am sure that we will complete all the preparations this week," Golikova reported to Putin, adding that the vaccination will be voluntary and free of charge. Vaccinations for Russian troops have already started and about 80,000 soldiers will get injections by the end of the year, while more than 400,000 servicemen will receive vaccines, Defense Minister Sergei Shoigu said last week. <keyword id="6358826" type="LOCATION" weightage="20" keywordseo="Russia">Russia</keyword> has developed two COVID-19 vaccines, namely Sputnik V and EpiVacCorona. A third one being developed so far is scheduled to have its clinical trials completed by the end of 2020. --IANS int/

Sputnik V vaccine: Russian President Putin orders mass COVID-19 vaccinations from next week

<ul><li>India may receive the first batch of Russia’s <keyword id="9739267" type="UNKNOWN" weightage="20" keywordseo="Sputnik-V">Sputnik V</keyword> COVID-19 vaccine is time for it to open up vaccinations for everyone above the age of 18 years.</li><li>The head of the <keyword id="1397612" type="COMPANY" weightage="20" keywordseo="Russian-Direct-Investment-Fund">Russian Direct Investment Fund</keyword> (RDIF) told Reuters that the vaccine will reach India by May 1.</li><li>The company plans to manufacture 850 million doses of Sputnik V annually in India, but a lot of that will depend on the momentum of technology transfer.</li></ul>India will receive the first batch of Russia’s Sputnik V COVID-19 vaccine by May 1. This is just in time for the country to open up vaccinations for everyone above the age of 18 years. “The first doses will be delivered on May 1,” the head of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, told <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/india-receive-first-batch-russias-covid-19-vaccine-may-1-interfax-2021-04-26/">Reuters</a>. However, he did not disclose the number of doses that will be a part of the first batch or where they will be manufactured. Sputnik V, developed by Moscow’s Gamaleya National Research Institute of Epidemiology and Microbiology, is the third vaccine after the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin to get approval from the Drug Controller General of India (DCGI). <div type="ExtQuote" text="“Following approval in India, it [Sputnik V] will be approved for use in 60 countries with a total population of over 3 billion people.”" auname="Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF) told reporters on April 14 after Sputnik V got the Drug Controller General of India’s (DCGI) approval"></div> RDIF is in charge of marketing the Sputnik V vaccine globally and has already signed agreements with six leading Indian manufacturers — Hetero Biopharma, Gland Pharma, Stelis Biopharma, Panacea Biotech, Virchow Biotech, and Shilpa Medicare. In this collaboration, RDIF hopes to manufacture over 850 million doses of the vaccine annually. By summer, it plans to hit 50 million doses a month and continue increasing output from there. A lot of this will depend on the momentum of technology transfer to allow Indian manufacturers to produce the vaccine. Virchow Biotech, for instance, is expected to complete its technology transfer between April to June, according to RDIF. Only then will it be able to commence full-scale commercial production of Sputnik V. The vaccine has also been approved by many of India’s neighbours including Sri Lanka, Myanmar and Pakistan. Russia is also lending a helping hand when it comes to Remdesivir. Pharmasyntez, a Russian company, announced that it is ready to ship up to 1 million packs of Remdesivir by the end of May, once it receives the prerequisite approval from the Russian government. <div type="Article" hostid="261" msid="82210121" title="Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors" mstype="2" mssubtype="0"></div> In India, the stocks of Remdesivir have been in short supply as demand for the anti-viral drug increased alongside the surge in cases. This is despite the fact that the <keyword id="6356311" type="COMPANY" weightage="20" keywordseo="World-Health-Organisation">World Health Organisation</keyword> (WHO) has reiterated that there is no conclusive evidence to support the fact that Remdesivir is effective in the treatment of COVID-19. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/the-pace-of-infections-and-test-positivity-in-maharashtra-is-slowing-down-but-it-is-too-soon-to-celebrate/articleshow/82256149.cms">The pace of infections and test positivity in Maharashtra is slowing down — but it is too soon to celebrate</a> <a href="https://www.businessinsider.in/india/news/india-covid-19-first-wave-versus-second-wave/articleshow/82216963.cms">'We're in a much better situation' claims India's Principal Scientific Advisor as COVID-19 claims more lives than ever before</a>

India will receive the first batch of Sputnik V COVID-19 vaccine by May 1 — in time for the third phase of its vaccination drive

<ul class="summary-list"><li>A <keyword id="114599" type="ORGANIZATION" weightage="60" keywordseo="European-Medicines-Agency">European Medicines Agency</keyword> official compared taking <keyword id="6358826" type="LOCATION" weightage="60" keywordseo="Russia">Russia</keyword>'s COVID-19 vaccine to Russian roulette.</li><li>She made the remark while urging countries to wait for the EMA's approval before authorizing it.</li><li><keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword>'s official Twitter account called the comments "inappropriate" and demanded an apology.</li></ul>Russia has demanded an apology from a top European Medicines Agency official after she said that approving the country's prized Sputnik V vaccine was like playing "Russian roulette."The EMA <a href="https://www.ema.europa.eu/en/news/ema-starts-rolling-review-sputnik-v-covid-19-vaccine">began rolling trials of Sputnik V on March 4</a>, but EU member states like Hungary have already approved the shot or, like Czechia and Slovakia, ordered batches from Moscow.Last month, Austria also <a href="https://tass.com/economy/1260805">expressed interest in approving Sputnik V</a>, prompting Christa Wirthumer-Hoche, the chief of the EMA management board, to urge caution."I would strongly advise against a national emergency authorization," Wirthumer-Hoche told Austria's ORF broadcaster Sunday, <a href="https://www.france24.com/en/live-news/20210308-eu-medical-official-warns-of-sputnik-jab-russian-roulette">according to Agence France-Presse</a>. "It's somewhat comparable to Russian roulette."On Monday, the verified Twitter account of the Sputnik V vaccine rollout scheme hit back at Wirthumer-Hoche's comments, calling them "inappropriate" and asking for an apology."We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V," it said."Her comments raise serious questions about possible political interference in the ongoing EMA review. Sputnik V is approved by 46 nations.""Such comments are inappropriate and undermine credibility of EMA and its review process," it added. "Vaccines and EMA should be above and beyond <keyword id="6358883" type="UNKNOWN" weightage="100" keywordseo="politics">politics</keyword>.In a Tuesday statement to <a href="https://tass.com/politics/1263875">the state-run TASS news agency</a>, the Kremlin spokesman Dmitry Peskov called Wirthumer-Hoche's remarks "regrettable" and "incorrect to say the least.""The demand for the vaccine and the vaccination campaigns in many countries indicate its relevance and popularity," Peskov said.In recent months, <a href="https://www.cnbc.com/2020/08/11/scientists-worry-whether-russias-sputnik-v-coronavirus-vaccine-is-safe-and-effective.html">much doubt has been cast on the safety of the Sputnik V vaccine</a>, which was given emergency-use approval by Moscow in August.Reports at the time said scientists developing the vaccine at the state-run Gamaleya Institute <a href="https://www.businessinsider.com/russia-says-coronavirus-vaccine-ready-production-september-criticized-rushed-2020-8">rushed through trials to please the Kremlin</a>.<div type="image" title="Vladimir Putin" height="1000" width="2000" msid="81430803" hostid="261"></div>The nationwide vaccination drive started in December, but Russians reportedly <a href="https://www.businessinsider.com/russia-coronavirus-vaccine-russians-split-2020-8">reluctant to take it up</a>."Once a country has blatantly violated all of the scientific and ethical rules about deploying a vaccine, it's hard to regain trust," Lawrence Gostin, a professor of medicine at Georgetown University, <a href="https://www.businessinsider.com/russia-sputnik-vaccine-40-countries-west-hoards-shots-2021-3">previously told Insider</a>.Despite the worries, the results of a late-stage trial <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext">published in The Lancet</a> in February found Sputnik V was 92% effective against COVID-19. The Russian Foreign Ministry <a href="https://www.businessinsider.com/politics-sputnik-v-rosians-offered-vaccines-against-covid-19-to-foreign-diplomats">has also offered foreign diplomats working in Russia shots of the vaccine</a>, but those representing European nations have chosen to wait for EMA approval. While the EMA and US Food and Drug Administration have yet to approve Sputnik V, Russia has signed deals to sell batches to countries around the world. So far, 46 countries have approved Sputnik V, according to the Gamaleya Institute. <h2>European doubts</h2>The deals have drawn skepticism from European officials.Last month, European Commission President Ursula Von Der Leyen questioned why Russia was selling its vaccine stores instead of vaccinating its people. "We still wonder why Russia is offering theoretically millions and millions of doses while not sufficiently progressing in vaccinating their own people," she <a href="https://www.politico.eu/article/vdl-questions-why-russia-is-selling-sputnik-vaccine-abroad-before-jabbing-own-citizens/">said</a>.While the EMA has not been in a rush to approve Sputnik V, <a href="https://www.businessinsider.com/russia-to-make-sputnik-v-vaccine-in-italy-a-1st-in-eu-2021-3">it was announced</a> on Tuesday that Russia had signed a deal to produce Sputnik V in Italy, the first manufacturing site outside the country.While <a href="https://www.bloomberg.com/news/articles/2021-02-12/putin-pitches-russia-s-covid-19-vaccine-but-still-won-t-take-it">President Vladimir Putin</a> and Russian state media <a href="https://www.rt.com/russia/500567-astrazeneca-oxford-trial-resumes-reaction/">championed Sputnik V</a>, the US has also accused Russian intelligence services of working to smear the vaccine made by Pfizer, an American company.A State Department official said Russian operatives were <a href="https://www.businessinsider.com/russia-trying-to-sow-public-doubt-about-pfizer-covid19-vaccine-2021-3">planting news articles</a> online that cast doubt on the efficacy of the shot, <a href="https://www.wsj.com/articles/russian-disinformation-campaign-aims-to-undermine-confidence-in-pfizer-other-covid-19-vaccines-u-s-officials-say-11615129200?mod=hp_lead_pos1">The Wall Street Journal reported</a>."We can say these outlets are directly linked to Russian intelligence services," the official said. "They vary a lot in their reach, their tone, their audience, but they're all part of the Russian propaganda and disinformation ecosystem."

Russia demanded an apology from the EU drug regulator after its top official compared getting the Sputnik V vaccine to playing 'Russian roulette'

<ul class="summary-list"><li>Russian President <keyword id="43440" type="PERSON" weightage="60" keywordseo="Vladimir-Putin">Vladimir Putin</keyword> announced that he wants tourists to visit <keyword id="6358826" type="LOCATION" weightage="60" keywordseo="Russia">Russia</keyword> to get the new <keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword> <keyword id="8904563" type="UNKNOWN" weightage="60" keywordseo="covid-19-vaccine">COVID-19 vaccine</keyword>.</li><li>The Sputnik V is still under review by the World Health Organization and European Medicines Agency.</li><li>Russia is currently reporting nearly 9,000 new <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword> cases per day.</li></ul>Russian President Vladimir Putin wants to encourage "vaccine tourism," where foreign citizens can visit the country to get a free Sputnik V COVID-19 vaccine."There is widespread practice where business people and heads of companies come specifically to Russia to get a jab against the <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword>," Putin told the St. Petersburg <keyword id="6356001" type="UNKNOWN" weightage="100" keywordseo="international">International</keyword> Economic Forum, <a href="https://www.themoscowtimes.com/2021/06/04/putin-wants-vaccine-tourism-plan-by-end-june-a74117">the Moscow Times reported.</a>He added that he wanted "to be able to organize the conditions for foreign citizens to come to Russia and get vaccinated on a commercial basis."The Russian Direct Investment Fund, the organization that's promoting Sputnik V COVID-19 vaccine, <a href="https://twitter.com/sputnikvaccine/status/1400758614063828995">said on Twitter on Friday</a> that vaccine tourism would launch by July.The country is advocating for the Sputnik V, but the vaccine is <a href="https://www.themoscowtimes.com/2021/06/03/who-europe-medicines-agency-finishing-sputnik-v-review-reports-a74096">still under review</a> by the World Health Organization and the European Medicines Agency. Unlike the Moderna and Pfizer "MRNA vaccines" that are popular in the US, the Sputnik V is a <a href="https://www.dw.com/en/is-sputnik-v-vaccine-safe/a-57219314">"viral vector vaccine"</a> akin to the AstraZeneca and Johnson &amp; Johnson COVID-19 vaccines.According to the <a href="https://www.themoscowtimes.com/2021/06/04/coronavirus-in-russia-the-latest-news-june-4-a69117">Moscow Times</a>' COVID-19 case tracker, Russia is currently reporting around 9,000 new COVID-19 cases per day.

Putin wants to lure vaccine tourists to Russia so foreigners can get the Sputnik V COVID-19 jab

<ul class="summary-list"><li><keyword id="6358826" type="LOCATION" weightage="60" keywordseo="Russia">Russia</keyword> has demanded <keyword id="72851" type="COUNTRY" weightage="60" keywordseo="Slovakia">Slovakia</keyword> hand back 200,000 doses of the <keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword> COVID-19 <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword>.</li><li>It followed Slovakia questioning the quality of the shots and saying they were not the same as those tested in trials.</li><li>The Russia Direct Investment Fund (RDIF) accused Slovakia of an "act of sabotage."</li></ul>Russia and Slovakia are arguing over the quality of <a href="https://www.businessinsider.com/how-4-covid-vaccines-not-available-in-us-stack-up-2021-3" target="_blank" rel="noopener">the Sputnik V vaccine.</a>Russia on Thursday demanded Slovakia give back 200,000 doses of its Sputnik V COVID-19 vaccine so they could be "used in other countries," citing a breach of contractual obligations, after the Slovak drug agency raised concerns about the shot.Slovakia's State Institute for Drug Control said earlier Thursday that about 80% of the data required to evaluate Sputnik V's safety and effectiveness was missing, despite multiple requests. It was worried about the quality of 200,000 doses that the country had received, it said. The agency said that Slovakia's Sputnik V doses were not the same as those tested in clinical trials published in the<a href="https://www.businessinsider.com/russia-coronavirus-vaccine-phase-3-interim-results-lancet-2021-2" target="_blank" rel="noopener"> Lancet medical journal in February</a>, which showed the vaccine was 91.6% effective at preventing COVID-19.Zuzana Batova, head of Slovakia's Institute for Drug control (SUKL), told <a href="https://www.tasr.sk/tasr-clanok/TASR:20210409TBB00055" target="_blank" rel="noopener">Slovak news agency TASR</a> that the Sputnik vaccine doses imported to Slovakia could not be compared with those used abroad. "They are connected only by name," she said. The Russia Direct Investment Fund (RDIF), which has funded the shot, denied the agency's claims, calling it a "disinformation campaign against Sputnik V" and an "act of sabotage" <a href="https://twitter.com/sputnikvaccine/status/1380158704704761861" target="_blank" rel="noopener">on Twitter.</a>"All Sputnik V batches are of the same quality and undergo rigorous quality controls," it said, adding that the RDIF requested on Tuesday that the Slovak government returned the vaccine doses due to "multiple contract violations so that it can be used in other countries." SUKL denied any contract breaches.Igor Matovic, Slovakia's finance minister, flew to Moskow Thursday to meet with Kirill Dmitriev, head of RDIF, to sort out "technical matters related to supplying Slovakia with the vaccine," per <a href="https://www.tasr.sk/tasr-clanok/TASR:20210409TBB00055" target="_blank" rel="noopener">TASR</a>. Matovic said that he'll present more details Friday,<a href="https://www.tasr.sk/tasr-clanok/TASR:20210409TBB00055" target="_blank" rel="noopener"> TASR reported.</a> Read more: <a href="https://www.businessinsider.com/coronavirus-vaccine-tracker-top-covid-shots-to-watch-in-2021" target="_blank" rel="noopener">COVID-19 Vaccine Tracker: AstraZeneca's shot proves safe and effective, and is headed to the FDA</a>Roughly 14% of Slovakia's 5 million population have received at least one dose of a COVID-19 vaccine, <a href="https://ourworldindata.org/covid-vaccinations" target="_blank" rel="noopener">according to Oxford University's Our World in Data.</a> By comparison, at least 46% of Brits and 33% of Americans have had a single dose.Sputnik V is under review for use in <keyword id="28249" type="COMPANY" weightage="60" keywordseo="europe">Europe</keyword> by the European Medicines Agency (EMA), but hasn't yet been approved. Individual countries in the EU can make their own decisions regarding which vaccines to roll out.Sputnik V is <a href="https://www.businessinsider.com/russia-sputnik-vaccine-40-countries-west-hoards-shots-2021-3" target="_blank" rel="noopener">approved for use</a> in 59 countries globally, <a href="https://rdif.ru/Eng_fullNews/6685/" target="_blank" rel="noopener">according to RDIF</a>. Slovakia is on the list, but nobody in Slovakia has been given a Sputnik V vaccine yet because SUKL is still looking at its data. Slovakia was the second European country, after Hungary, to <a href="https://www.businessinsider.com/eu-vaccine-rollout-failing-russia-and-china-are-stepping-in-2021-3" target="_blank" rel="noopener">look to Russia to </a>speed up <a href="https://www.businessinsider.com/how-europe-failed-covid-vaccine-rollout-lockdown-france-germany-eu-2021-3" target="_blank" rel="noopener">its slow vaccine rollout.</a>Igor Matovic, who was prime minister at the time, secured a secret deal for 2 million vaccines in early March, a divisive decision that cast doubt on allegiances to the West. Matovic and Marek Krajci, former <keyword id="6354750" type="UNKNOWN" weightage="60" keywordseo="health">health</keyword> minister, stepped down from their positions in March.

Russia demanded 200,000 Sputnik V vaccines back after officials in Europe questioned the quality of the shot

<ul><li>The vaccine that will have to be taken in two doses, will cost less than $10 (₹740) in international markets.</li><li>However, the vaccine will be available free of charge for Russian citizens. </li><li><keyword id="10325662" type="UNKNOWN" weightage="20" keywordseo="russias-sputnik-v-vaccine">Russia’s Sputnik V vaccine</keyword> has an efficacy of 95% after 42 days of the first dose. </li></ul>Russia’s Sputnik V vaccine has an efficacy of <a href="https://www.ndtv.com/world-news/coronavirus-russia-says-sputnik-v-covid-19-95-effective-news-agency-afp-2329561">95%</a> after 42 days of the first dose. The results were released by Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF). For the study, 22,000 volunteers had been vaccinated for the first dose and more than 19,000 volunteers with the first and second doses. The vaccine that will have to be taken in two doses, will cost less than $10 (₹740) in international markets. However, the vaccine will be available free of charge for Russian citizens. According to its current capacity, Sputnik V vaccine will be produced abroad for 500 million people per year, starting from 2021. “Sputnik V will be two or more times cheaper than mRNA vaccines with similar efficacy levels,” said the official statement. One of the international partners for the<a href="https://www.businessinsider.in/science/health/news/the-race-for-covid-19-vaccine-heres-how-moderna-pfizer-and-sputnik-v-vaccines-stack-up-against-each-other/articleshow/79263801.cms"> Sputnik V vaccine</a> is India, however requests for more than 1.2 billion doses of Sputnik V vaccine have come in from over 50 countries. “The Gamaleya Center has developed one of the most efficient vaccines against coronavirus in the world with an efficacy rate of more than 90% and a price that is two times lower than that of other vaccines with similar efficacy rate. We are ready to start deliveries of the Sputnik V vaccine to foreign markets thanks to partnerships with manufacturers in India, Brazil, South Korea, China and four other countries,” said Kirill Dmitriev, CEO, Russian Direct Investment Fund in a statement. The news of <keyword id="10325661" type="UNKNOWN" weightage="20" keywordseo="russias-vaccine">Russia’s vaccine</keyword> follows the positive news from Pfizer, Moderna and Oxford Astrazeneca — all of whom are progressing rapidly with their vaccine trials and are claiming success so far. <a href="https://www.businessinsider.in/science/health/news/the-oxford-covid-19-vaccine-will-only-cost-the-indian-government-3-per-dose-reveals-adar-poonawalla/articleshow/79371741.cms">Serum Institute of India</a> which will distribute the Oxford Astrazeneca vaccine had said that India will be a priority and will cost the Indian government $3 per dose. SEE ALSO: <a href="https://www.businessinsider.in/science/health/news/the-oxford-covid-19-vaccine-will-only-cost-the-indian-government-3-per-dose-reveals-adar-poonawalla/articleshow/79371741.cms">The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla</a>

Russia’s Sputnik V vaccine is 95% effective — each dose will cost less than $10 internationally but will be free for Russians

<ul class="summary-list"><li>Mass vaccination campaigns are being rolled out around the world as governments look for ways to contain the spread of <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword>.</li><li>Pfizer-BioNTech, Oxford-AstraZeneca, <keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword>, and Sinopharm are among the authorized vaccines being distributed in multiple countries.</li><li>But Russia, India, and China have been criticized for rushing their <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> approval processes, and some people remain skeptical about getting inoculated.</li><li>As wealthier nations expand their immunization efforts, many developing countries struggling with the pandemic are still waiting for their shots.</li></ul>Mobile freezers brought onto boats and carried by motorbikes - this is what it takes to deliver measles and Ebola vaccines to remote parts of Congo. The efforts were essential to control those outbreaks, and they can teach us lessons on how to bring the new COVID-19 vaccines to billions of people living in isolated areas of the world. "There's lots of rivers, there's lots of jungles, there's mountains, and there's very few paved roads," said John Johnson, an emergency coordinator with Doctors Without Borders.But delivery of coronavirus shots to these places is still months, <a href="https://www.businessinsider.com/poor-countries-may-wait-years-covid-19-vaccines-2020-11">if not years</a>, away. Despite record levels of infections, many developing countries can't afford to secure vaccines right now and will have to wait on aid.Meanwhile, richer nations are well underway. <h2>Russia's Sputnik V vaccine is making its way around the world. </h2>Russia was the first country to give approval to a human vaccine. Now it's close to giving the green light to one for domestic animals susceptible to contracting the virus from humans.But the country's handling of these efforts has been <a href="https://www.businessinsider.com/russia-approves-coronavirus-vaccine-experts-say-needs-more-testing-2020-8">widely criticized</a>. Its coronavirus vaccine, Sputnik V, received regulatory approval in August, when it had only been tested on a few dozen people.In December, Russia launched a mass vaccination campaign before full trials had finished."I think only time will tell, and that's it," said nurse Natalia Shvekova. "Well, I don't know, but I believe the more people get vaccinated, the better it will be for our health."But that isn't a popular view among Russians. Recent polls have found that more than half of the country doesn't plan on getting the vaccine, at least not until there's more information.Still, doses of Sputnik V are making their way around the world. Just before Christmas, Argentina became the third country to <a href="https://markets.businessinsider.com/news/stocks/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-1029917789">approve the treatment</a>, after Russia and Belarus.Governments are anxious to gain some sort of control over the pandemic, and it turns out Sputnik V is much <a href="https://www.insider.com/russias-sputnik-v-vaccine-to-be-cheaper-than-rivals-says-fund-head-2020-11">cheaper</a> than the vaccines made by Russia's Western rivals.<h2>Distribution of the Pfizer-BioNTech vaccine has resulted in long lines around the world.</h2><div type="image" title="Vax pic 210" height="1080" width="1920" msid="80160376" hostid="261"></div>The UK was the <a href="https://www.businessinsider.com/pfizer-and-biontech-covid-19-vaccines-approved-by-uk-regulator-2020-11">first to approve</a> Pfizer-BioNTech's vaccine for emergency use. Canada, the US, and the European Union quickly followed suit."It is a significant step forward in our fight against this pandemic, which is causing suffering and hardship for so many people, not just in Europe," said Emer Cooke, executive director of the European Medicines Agency.All over the world, distribution of the <keyword id="44612" type="CITY" weightage="60" keywordseo="Pfizer">Pfizer</keyword> vaccine is resulting in long lines like the ones often seen for COVID tests, as well as makeshift clinics like the ones used for COVID patients.Many felt relief."It's a day of much excitement, seeing this helicopter transporting hope," the president of Chile, Sebastián Piñera, said.Maria Irene Ramirez, a nurse in Mexico, added, "It's the best gift in 2020 I could have gotten."But some are still skeptical. "I am not willing to inject myself with something that I don't know where it was made, what's in it, who touched, who didn't touch it," Jerusalem resident Avishai Atias shared.<h2>The US is off to a slow start vaccinating Americans while other countries are working on their own vaccines.</h2>In the US, mistrust of vaccines has <a href="https://news.gallup.com/poll/327425/willingness-covid-vaccine-ticks.aspx">gradually declined</a>.The Food and Drug Administration gave emergency use authorization to both Pfizer's treatment and a second one developed by <keyword id="4912868" type="PERSON" weightage="60" keywordseo="moderna">Moderna</keyword>, <a href="https://www.businessinsider.com/fauci-got-his-first-coronavirus-vaccine-dose-live-on-tv-2020-12">widening the reach</a> of the country's immunization effort.But the nation with the most infections in the world is off to a slower than expected start. 20 million Americans were supposed to get a shot by the end of 2020. Only <a href="https://www.businessinsider.com/challenges-with-us-coronavirus-vaccine-distribution-warp-speed-goal-2020-12">about 3 million</a> did.Back in the UK, a second vaccine by Oxford-AstraZeneca was also approved just before the new year.Unlike Pfizer's, it doesn't need to be stored in frigid temperatures - making it much <a href="https://www.businessinsider.com/oxford-covid-19-vaccine-pfizer-moderna-compared-astrazeneca-cheaper-temperature-2020-11">easier to transport and store</a>.India has since given the Oxford shot a green light as well, manufacturing a local version called Covishield."It is free across the country," said Indian health minister Harsh Vardhan.India also approved its own government-backed vaccine called Covaxin. But many health experts worry about Covaxin's missing efficacy data, calling the authorization <a href="https://www.bbc.com/news/world-asia-india-55526123">rushed</a>. China has heard similar critiques about its vaccination programs. <a href="https://www.businessinsider.com/china-giving-coronavirus-vaccine-candidate-key-workers-2020-8">Since the summer</a>, it's been administering unproven, homegrown vaccines to parts of its population.Among these is the CoronaVac, made by the company Sinovac.It's already been used on some high-risk groups in China, while being tested in Brazil, Chile, Turkey, and Indonesia. The Chinese state-owned company Sinopharm also has vaccines in development. Despite a <a href="https://www.businessinsider.com/china-approves-sinopharm-vaccine-2020-12">lack of transparency</a> around trial data, the United Arab Emirates and Bahrain have been the first two countries to approve of a Sinopharm vaccine."It was my duty as a Bahraini female and as a doctor as well to take this vaccine, and to be one of the pioneers to take it," said resident Mai Bobshet.<h2>It's impossible to ignore the role of <keyword id="6358883" type="UNKNOWN" weightage="60" keywordseo="politics">politics</keyword> in the vaccine rollout.</h2>Much of the story about whose shots are approved where is turning out to be a political one.In Hungary, the dilemma is noticeable. Even though the country is part of the European Union, and Pfizer's vaccine is already being rolled out, the government is still considering more doses from China and Russia."Countries are playing, and our leaders or politicians are playing, a game," said Balazs Rekassy, health policy advisor to the mayor of Budapest. "Which vaccine can they get first? Hungary is in a special situation, because it is in the middle from East and West."But for the coronavirus, there is no distinction between East and West.And <a href="https://www.businessinsider.com/coronavirus-vaccine-rich-nations-leave-rest-scrambling-supplies-2020-12">those with resources</a> will need to make sure the rest of the world can get its shots, too.

COVID-19 vaccines are making their way around the world, but global immunity is still far off

<ul><li>Russia is likely to sell 100 million doses of its COVID-19 vaccine — Sputnik-V — to Indian pharmaceutical Dr Reddy’s Laboratories</li><li>According to the Russian Direct Investment Fund, the deliveries can begin in the late 2020.</li><li>Sputnik V is under Phase III trials in Russia. Gamaleya Research Institute — a part of Russia’s Health Ministry — is testing the vaccine on over 40,000 people.</li></ul>Russia is likely to sell 100 million doses of its COVID-19 vaccine — Sputnik-V — to Indian pharmaceutical Dr Reddy’s Laboratories as soon as it receives regulatory approval in India,<a href="https://in.reuters.com/article/health-coronavirus-russia-reddys/russia-to-sell-covid-19-vaccine-to-indias-dr-reddys-laboratories-idINKBN2671DY?il=0"> reported Reuters. </a> "On regulatory approval in India, RDIF (Russian Direct Investment Fund) shall supply to Dr Reddy's 100 million doses of the vaccine. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic," said a statement from the fund. The development comes after the Russian government sought India’s help, earlier this month, in manufacturing the Sputnik V vaccine and also to conduct Phase III trials in India. According to the Russian Direct Investment Fund, the deliveries can begin in the late 2020. "The agreement between RDIF and Dr Reddy's reflects the growing awareness of countries and organisations to have a diversified anti-COVID vaccine portfolio to protect their populations," RDIF added. Sputnik V is under Phase III trials in Russia. Gamaleya Research Institute — a part of Russia’s Health Ministry — is testing the vaccine on over 40,000 people. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/brinton-pharma-which-recently-got-dcgi-approval-to-launch-covid-19-drug-favipiravir-in-india-gets-10-crore-in-debt-funding/articleshow/78145260.cms">Brinton Pharma, which recently got DCGI approval to launch COVID-19 drug Favipiravir in India, gets ₹10 crore in debt funding</a>

You Searched For "Sputnik V corona vaccine" and got 10 results

Putin said he got a coronavirus vaccine but released no photos and won't say which one he took

Marianne Guenot

COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response

BI India Bureau

Sputnik V vaccine: Russian President Putin orders mass COVID-19 vaccinations from next week

IANS

India will receive the first batch of Sputnik V COVID-19 vaccine by May 1 — in time for the third phase of its vaccination drive

Prabhjote Gill

Russia demanded an apology from the EU drug regulator after its top official compared getting the Sputnik V vaccine to playing 'Russian roulette'

Bill Bostock

Putin wants to lure vaccine tourists to Russia so foreigners can get the Sputnik V COVID-19 jab

Kelly McLaughlin

Russia demanded 200,000 Sputnik V vaccines back after officials in Europe questioned the quality of the shot

Dr. Catherine Schuster-Bruce

Russia’s Sputnik V vaccine is 95% effective — each dose will cost less than $10 internationally but will be free for Russians

Sanchita Dash

COVID-19 vaccines are making their way around the world, but global immunity is still far off

Hannah Jiang,Dylan Bank

India’s Dr Reddy’s Lab to get 100 million doses of Russia’s COVID-19 vaccine after regulatory approval

BI India Bureau

Popular Keywords

Buying Guides